FDA — authorised 15 September 1982
- Application: NDA017381
- Marketing authorisation holder: KING PHARMS LLC
- Indication: Manufacturing (CMC)
- Status: approved
🇺🇸 Silver Sulfadiazine in United States
FDA authorised Silver Sulfadiazine on 15 September 1982
Marketing authorisations
FDA — authorised 17 November 1986
- Application: NDA018810
- Marketing authorisation holder: THEPHARMANETWORK LLC
- Indication: Manufacturing (CMC)
- Status: approved
FDA — authorised 15 March 1989
- Application: NDA018578
- Marketing authorisation holder: DR REDDYS
- Indication: Manufacturing (CMC)
- Status: approved
FDA
- Marketing authorisation holder: THEPHARMANETWORK LLC
- Status: approved
Silver Sulfadiazine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Silver Sulfadiazine approved in United States?
Yes. FDA authorised it on 15 September 1982; FDA authorised it on 17 November 1986; FDA authorised it on 15 March 1989.
Who is the marketing authorisation holder for Silver Sulfadiazine in United States?
KING PHARMS LLC holds the US marketing authorisation.